FIVE PRIME THERAPEUTICS INC Collaboration Agreements

21 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
License and Collaboration Agreement, dated as of December 19, 2017, by and between the company and Zai Lab (Shanghai) Co., Ltd
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2018
Amendment No. 1 to the License and Collaboration Agreement by and between the company and Zai Lab (Shanghai) Co., Ltd., dated as of December 21, 2018
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2019
Amendment No. 1 to the Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
2016
Amendment No. 3 to the Respiratory Diseases Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2016
Amendment No. 2 to the Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2016
Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
CA
2015
CLINICAL TRIAL COLLABORATION AGREEMENT
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2015
Amendment No. 1 to the Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
Amendment No. 2 to the Respiratory Diseases Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2014
Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2014
AMENDMENT No. 1 to the RESEARCH COLLABORATION AND LICENSE AGREEMENT (Muscle Diseases ResearchProgram Expansion)
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between GlaxoSmithKline LLC and Five Prime Therapeutics, Inc. RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
RESPIRATORY DISEASES RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
License andCollaboration Agreement by and between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc. LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
AMENDMENT No. 1 to the RESEARCH COLLABORATION AND LICENSE AGREEMENT (Muscle Diseases ResearchProgram Expansion)
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between GlaxoSmithKline LLC and Five Prime Therapeutics, Inc. RESEARCH COLLABORATION AND LICENSE AGREEMENT
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
Amendment No. 1 to the Respiratory Diseases Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
RESPIRATORY DISEASES RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between Glaxo Group Limited and Five Prime Therapeutics, Inc.
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
DE
2013
License andCollaboration Agreement by and between Five Prime Therapeutics, Inc. and Human Genome Sciences, Inc. LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013
Research Collaboration and License Agreement
Collaboration Agreements
FIVE PRIME THERAPEUTICS INC
Biotechnology
NY
2013